BioSpace News Archive

Drug Development

Bristol-Myers Squibb’s Opdivo Fails to Show Superiority to Bayer’s Nexavar in Liver Cancer

The drug failed to meet statistical significance for overall survival. However, the company is putting a positive spin on it, saying it showed a clear improvement trend in OS for patients treated with Opdivo compared to sorafenib.

June 24, 2019
·
2 min read
·
Mark Terry
Drug Development

MyoKardia Publishes Data in Nature Digital Medicine Showing Potential of Wrist-Worn Biosensor to Screen for Hypertrophic Cardiomyopathy

Continuous Monitoring with Wearable Device Detected Distinct Pulse Wave Patterns in Obstructive Hypertrophic Cardiomyopathy Patients as Compared to Healthy Volunteers

June 24, 2019
·
5 min read
Pharm Country

5WPR Healthcare PR Practice Area Named Top 20 in U.S.

O’Dwyers, a leading public relations industry publication, has officially released its annual PR rankings naming 5W Public Relations’ Healthcare PR practice area among the top twenty in the U.S.

June 24, 2019
·
1 min read
VALBIOTIS Participates in the First HealthTech Investor Days, Organized by France Biotech

VALBIOTIS announced that it has been selected to participate in the first HealthTech Investor Days, being held June 24-25 in Paris.

June 24, 2019
·
3 min read
BioCapital

Negative Pressure Wound Therapy Market to hit $2.5bn by 2025: Global Market Insights, Inc.

The negative pressure wound therapy market is predicted to hike from USD 1.7 billion in 2018 to around USD 2.5 billion by 2025, according to a 2019 Global Market Insights, Inc.

June 24, 2019
·
2 min read
Drug Development

FDA Grants Orphan Drug Designation to XW Laboratories’ XWL-008 for the Treatment of Patients with Narcolepsy

XW Laboratories Inc. announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to the company’s lead proprietary compound XWL-008 for the treatment of patients with narcolepsy.

June 24, 2019
·
2 min read
Drug Development

MaaT Pharma Completes Third Positive DSMB Assessment Setting High Safety Standard for Human Intestinal Microbiome Whole Ecosystem-Based Therapeutics

Independent Data Safety Monitoring Board (DSMB) confirms continuation of Phase II HERACLES study in acute GvHD with no safety concerns occurring within the study

June 24, 2019
·
5 min read
Policy

/R E P E A T -- Notice to the media - Government of Canada to announce support for active lifestyle and the prevention of chronic disease for Prince Edward Islanders/

On behalf of the Honourable Ginette Petitpas Taylor, Federal Minister of Health, Member of Parliament, Sean Casey will announce funding for a project that will increase physical activity levels for older adults living in P.E.I.

June 24, 2019
·
1 min read
Policy

/R E P E A T -- Notice to Media - Minister of Health to visit the Greater Toronto Area/

The Honourable Ginette Petitpas Taylor, federal Minister of Health, will visit Toronto and Brampton to deliver health-related announcements.

June 24, 2019
·
1 min read
Policy

Organigram Receives Health Canada Approval for an Additional 17 Cultivation Rooms in Phase 4A

Additional licensed cultivation space brings annual target production capacity to 61,000 kg/yr1

June 24, 2019
·
6 min read